Document is current
Any future updates will be listed below
-
Authors
Shinde, Shraddha
Thieu, Vivian Thuyanh
Kwan, Anita Y. M.
Houghton, Katherine
Meyers, Juliana
Schapiro, David
-
Funding
Funding for this research was provided by:
Eli Lilly and Company
- License Information
-
More Information
Article History
Received: 23 August 2023
Accepted: 13 November 2023
First Online: 1 December 2023
Declarations
:
: Shraddha Shinde, Vivian Thuyanh Thieu, Anita YM Kwan and David Schapiro are employees and shareholders of Eli Lilly and Company. Katherine Houghton and Juliana Meyers are employees of RTI Health Solutions. RTI Health Solutions received funding from Eli Lilly and Company to conduct this study.
: This study was conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki and that are consistent with Good Pharmacoepidemiology Practices and applicable laws and regulations of the country or countries where the study was conducted, as appropriate. Participants’ data were deidentified to protect privacy. A formal Consent to Release Information form was not required since this was an observational study that used previously collected data and did not impose any form of intervention.
